Winter Season - Week 11

Hold fast to dreams, for if dreams die, life is a broken winged bird that cannot fly. ~Lanston Hughes

Fundraising Tip
Provide a Service like painting, cleaning, babysitting, shopping, etc. People also like to receive a service at a reduced price especially when they know their funds will go to a good cause.

Training Tip
What to wear. Choose clothing that wicks moisture and fits comfortably. On runs that last a couple of hours, some chafing can usually be expected. Use petroleum jelly or a product like Body Glide on friction-prone areas such as your feet and upper thighs. Women should watch out for chafing around the seams on sports bras. Guys should make sure their nipples are protected -- Band-Aids are a simple solution that can prevent chafing.

Frequently Asked Questions
What is TNT's committment to you?
• Travel, accommodations, and entry fees for event weekend.
• Four or five months of supervised coaching including comprehensive training schedules, and opportunities to train with other Team Members.
• Professional advice on nutrition, injury prevention, and other related topics.
• Fundraising materials, ideas, and strategies.
• Support and encouragement throughout the fundraising and training period.

What is your commitment to TNT?
• Raise the minimum amount of funds designated to aid researchers in their race to find a cure for leukemia and related cancers.
• Train to run, walk, or cycle the marathon, half marathon, century ride or triathlon for which you are registered.

TNT In The News
The Gresham Outlook
www.theoutlookonline.com

Tam Driscoll sets fundraising record for Lymphoma Society
http://www.theoutlookonline.com/news/story.php?story_id=125685722649214800
She did it! Tam Driscoll, who works in Gresham City Hall, is this fall’s top fundraiser in the nation for The Leukemia & Lymphoma Society’s Team in Training. So far, she’s raised more than $58,000, putting her past her goal of $55,000 – the amount needed for Driscoll to work with researchers on one of three studies on non-Hodgkin lymphoma, the same type of cancer that killed her sister, Nancy Driscoll, in June at the age of 56. The amount Driscoll raised is a record for the society’s Oregon chapter, Driscoll said. Second-place fundraising honors went to a California woman who raised $43,000 for The Leukemia & Lymphoma Society. Driscoll’s fundraising efforts were part of her training for the Nike Women’s Marathon on Sunday, Oct. 18. The weekend also included a Friday, Oct. 16, fundraiser party in which Driscoll was the guest speaker.

Mission Moment
Gail Alice Denker
Batavia, IL
United States
female
Living with CML for 7 years
Age: 67
I was 61 years old when diagnosed, newly retired and had just found out my husband and I were going to become grandparents for the first time.

My diagnosis came 5 months before Gleevec was approved by the FDA. Fortunately for me, a trial was beginning at OHSU, conducted by Dr. Brian Druker (who developed the drug) and Dr. Michael Mauro, who became my oncologist at OHSU. I enrolled as patient 001 in the trial to treat newly diagnosed, untreated CML patients.

The trial ended successfully for me. A year later I was in full remission and able to harvest my stem cells. Although I was subsequently diagnosed with breast cancer that same summer (DCIS and LCIS) for which I had bilateral mastectomies, I have remained in full remission for 6 years.
I could not have faced this without the support of my husband, Merle, an orthopedic surgeon who became my personal physician and administered my shots with kindness and patience. My husband and I have been able to enjoy our retirement winters in Southern California, and we are now the proud grandparents of two lovely granddaughters and two darling grandsons.

I feel very blessed to have been diagnosed at the time that Gleevec was being developed, which erased the original prognosis of 3-5 years. I owe my life to Dr. Robert Bayer, my oncologist, who made my diagnosis and encouraged me to enroll in the study, and to Novartis and Drs. Druker and Mauro, as well as the Leukemia and Lymphoma Society, for defeating a once fatal disease.